Clin2
NCT07566572Possibly a fitRecruiting

Safety Study of BGM0504 Tablets in Healthy Chinese Adults

Chinese Healthy Volunteers

Treatments studied

This is an early-stage safety study testing a new tablet called BGM0504 in healthy volunteers. Researchers want to understand how the body handles this drug and check for any side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
144 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Age 18–55 years old and in generally good health with no major medical conditions
  • Weight at least 50 kg and BMI between 24.0 and 29.9 (not underweight or obese)
  • Stable weight (no more than 5% change in the past 12 weeks)
  • No history of severe allergies or reactions to medications
  • No use of prescription or over-the-counter drugs (including vitamins and herbal products) within 2 weeks before the study
  • Willing to use contraception for 3 months after the last dose and not donate sperm or eggs

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07314541Not yet recruiting· Phase 1
KMY Tablets Safety Study in Healthy Adults

This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.

Suzhou, Jiangsu
NCT06839131Recruiting· Phase 1
Study of SPH9788 tablets in healthy Chinese volunteers

This trial tests a new medicine called SPH9788 in healthy people to see how the body handles it. Volunteers must be generally healthy and follow lifestyle rules to help researchers understand the drug's safety and effects.

Shanghai
NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang
NCT07254481Recruiting· Phase 1
Safety study of VB19055 in healthy volunteers

This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.

Hangzhou
NCT07469085Recruiting· Phase 1
Safety study of SV003 in healthy volunteers

This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.

Shanghai
NCT07239973Recruiting· Phase 1
Study of BGM0504 Tablets for overweight or obese adults

This trial tests a new tablet, BGM0504, in healthy adults who are overweight or obese but do not have diabetes. It aims to see how the medicine works and if it is safe for this group.

Kunming, Yunnan

Hear when a new Chinese Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.